Is Quest Diagnostics Incorporated a good dividend stock?

Quest Diagnostics Incorporated (DGX) is a dividend-paying stock with a current dividend yield of 1.64%. Review its dividend history, payout consistency and growth to judge whether it fits your income strategy.

What is DGX's dividend yield?

The dividend yield for DGX stock is currently 1.64%.

How much does DGX pay in dividends per year?

Quest Diagnostics Incorporated pays an annual dividend of $3.3200 per share over the trailing twelve months.

How often does DGX pay dividends?

DGX stock pays dividends quarterly.

Is DGX's dividend growing?

Quest Diagnostics Incorporated's 3-year dividend CAGR is 6.61%.

DGX Stock Price, Chart, Stats & News

Quest Diagnostics Incorporated

Save

Overview Dividend safety Dividends Fundamentals

Quest Diagnostics Incorporated (DGX) is a dividend-paying stock with a current dividend yield of 1.64% as of Jul 15, 2026. It pays $3.32 per share over the trailing twelve months and distributes quarterly. Its dividend has grown at a 7.06% 5-year compound annual rate.

22.45B

Market cap

20.00x

Current P/E

19.34x

Forward P/E

1.64%

Dividend yield

$3.32

DGX dividend

Dividend safety

Strong

Dividend coverage looks healthy — DGX pays out about 33% of earnings.

See the safety analysis

DGX chart

Loading chart...

Fundamentals

Gross margin	33.25%
Operating margin	14.15%
Pretax margin	12.32%
Net margin	8.99%
Effective tax rate	23.09%
ROA	6.11%
ROE	13.88%
D/E	0.96x
Interest coverage ratio	5.70x

All financials

DGX valuation

P/E	20.00x
P/S	1.97x
P/B	3.03x
P/CF	11.51x
P/FCF	16.00x
P/OCF	11.51x
PEG	8.22x
EV multiple	7.50x

About

Health care

Sector

Medical - Diagnostics & Research

Industry

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients.